Nerve Sheath Tumors

These are rare tumors that start in the protective covering around nerves. Think of it like a sheath around a wire. These tumors can happen in nerves outside the brain and spinal cord (peripheral nerves) or inside the brain and spinal cord (central nerves). Common examples include neurofibromas and schwannomas.

Condition

What people with Nerve Sheath Tumors report

Every report comes from a Lived member, sent anonymously.

Have you had Neurosurgery for Nerve Sheath Tumors?

NameHow it went

About Nerve Sheath Tumors

What It Is

Nerve sheath tumors are growths that start in the cells forming the protective covering, or sheath, around nerves. Most arise on peripheral nerves, the nerves that run from the brain and spinal cord out to the limbs, trunk, head and neck. Most are benign, meaning they are not cancer and do not spread to other parts of the body. The two most common types are schwannomas and neurofibromas. A schwannoma usually grows as a single, contained lump beside the nerve fibers. A neurofibroma tends to grow intertwined with the nerve, and one form, the plexiform neurofibroma, can spread along several nerves and surrounding tissue. Rarer benign types include perineuriomas and hybrid tumors with mixed features. A vestibular schwannoma (also called acoustic neuroma), which grows on the nerve for hearing and balance, is a well-known form with its own symptoms and care. A small minority are malignant peripheral nerve sheath tumors (MPNST), a rare, fast-growing cancer that belongs to the sarcoma family. Telling the benign types apart from MPNST, and from lumps that have nothing to do with nerves, shapes the rest of care. Symptoms depend on where the tumor sits. Many people notice a lump, which may be painless. Pressure on the nerve can cause pain, numbness, tingling or weakness in the area that nerve supplies, and tapping the lump often sends a tingling or electric sensation along the nerve. Some tumors cause no symptoms and are found by chance on a scan.

Causes & Risk Factors

Most single nerve sheath tumors are sporadic: they appear without a known cause and are not inherited. Genetic conditions account for many people who have several tumors. Neurofibromatosis type 1 (NF1) causes neurofibromas, and about half of people with NF1 develop plexiform neurofibromas. NF2-related schwannomatosis (named for the NF2 gene) and other forms of schwannomatosis cause multiple schwannomas; in NF2-related schwannomatosis, tumors on the hearing and balance nerves are characteristic. About half of people with neurofibromatosis inherit it from a parent, while the rest have a new gene change. A person with NF1 has a 50% chance of passing it to each child. For MPNST, NF1 is the strongest known risk factor. Roughly a quarter to half of people with MPNST have NF1, and about 8% to 13% of people with NF1 develop MPNST during their lifetime, often from an existing plexiform neurofibroma. In NF1 it tends to appear in young adulthood, while MPNST without NF1 typically appears around age 50. MPNST can also develop in an area treated with radiation therapy, often decades later. Having a risk factor does not mean a tumor will develop or become cancerous.

How It's Diagnosed

Diagnosis starts with a careful neurological examination: where the lump is, whether tapping it causes tingling along the nerve, and whether sensation or strength is reduced in the area the nerve serves. That exam matters because nerve tumors are often mistaken for more common problems, such as a pinched nerve in the spine, a swollen lymph node, a fatty lump or another soft tissue tumor. In one specialist center's series, almost half of people with a benign nerve sheath tumor had first received a different diagnosis, and some had surgery under that wrong diagnosis that left lasting nerve damage. MRI (magnetic resonance imaging) is the main imaging test. It shows the tumor's size, its relationship to the nerve and features that point toward a benign tumor or a cancer. High-resolution ultrasound can identify tumors close to the surface, and nerve conduction tests can measure how well the nerve is working. When a tumor looks benign, nerve specialists usually avoid a needle biopsy beforehand, because it can injure the nerve; the diagnosis is confirmed when the removed tissue is examined. When MPNST is suspected, a biopsy is needed to confirm cancer, along with MRI, CT (computed tomography) or PET (positron emission tomography) scans to check whether it has spread. People with several tumors may be evaluated for NF1 or schwannomatosis, which can include skin and eye exams, hearing tests and sometimes genetic testing. Because these tumors are uncommon, it is worth having the assessment done by, or reviewed with, an experienced peripheral nerve surgeon or a sarcoma center before any biopsy or surgery.

Treatment Options

Treatment depends on the tumor type, its symptoms and whether it is growing. A benign tumor that causes no problems can often be watched with periodic exams or scans, and many never need treatment. Surgery is considered when a tumor grows, causes pain, numbness or weakness, or raises concern about cancer. Schwannomas usually sit inside a capsule beside the nerve fibers, so an experienced surgeon can typically remove them completely while preserving nerve function, and they rarely return after complete removal. Neurofibromas are harder to separate from the nerve, so removal carries a greater risk of new numbness or weakness. Perineuriomas are generally not removed, because taking them out would mean sacrificing the nerve. Surgeons use magnification and nerve monitoring during the operation to protect function. For people with NF1 whose plexiform neurofibromas cause symptoms and cannot be fully removed, two medicines taken by mouth are approved: selumetinib (Koselugo), for adults and children 1 year and older, and mirdametinib (Gomekli), for adults and children 2 years and older. Both are MEK inhibitors, which block MEK, a protein in a growth signal that is overactive in NF1 tumors. They are taken long term, require regular eye and heart checks, and can harm a developing baby, so effective contraception is needed. MPNST is treated like other high-grade sarcomas, ideally by a specialized team. Removing the whole tumor with a margin of healthy tissue is the only treatment that can cure it, even when that means sacrificing the affected nerve. Radiation therapy is often added before or after surgery to lower the chance of the tumor returning in the same place. Chemotherapy, usually based on doxorubicin, is used mainly when the tumor cannot be removed or has spread, and responses are often limited. Clinical trials are an important option.

What to Expect

For most benign tumors the outlook is good. Many people recover well after a schwannoma is removed and have no further trouble from it. Some numbness, tingling or weakness can persist or appear after surgery, particularly with neurofibromas or with tumors that had already damaged the nerve. A long delay in diagnosis can leave pain that becomes chronic. People with NF1 or schwannomatosis can develop new tumors over time. Regular follow-up, often yearly at a specialty clinic, tracks known tumors and watches for change, and most people with NF1 have an average life expectancy. Chronic pain is a common burden in schwannomatosis, and treatment often focuses on managing it. MPNST is a serious cancer. It often returns near the original site after surgery and can spread, and published five-year survival ranges from about a quarter to about two thirds of people, depending largely on tumor size, location, spread and whether it could be fully removed. Follow-up includes regular scans, and attention to pain, function and quality of life is part of care throughout.

When to Seek Help

Arrange a medical evaluation for a new lump near a nerve, especially one that sends tingling or shooting pain along a limb when touched, or for numbness, nerve pain or weakness in one area without a clear explanation. Ask whether a peripheral nerve specialist should see it before any biopsy or surgery. Contact your care team promptly if a known nerve sheath tumor starts growing quickly, becomes persistently painful, or is joined by new weakness or numbness. These changes need prompt assessment in anyone, and particularly in people with NF1, because they can be signs of MPNST.

Questions to Ask Your Doctor

  1. 1.Which type of nerve sheath tumor is this likely to be, and how certain can we be without removing it?
  2. 2.Should this tumor be watched or removed, and what is the chance of new numbness or weakness after surgery?
  3. 3.Will a peripheral nerve surgeon or sarcoma center be involved in planning my care?
  4. 4.Should I be evaluated for NF1 or schwannomatosis, and would genetic testing help my family?
  5. 5.Which changes in the tumor should prompt me to contact you before my next scheduled visit?

Last reviewed • Oct 2026

Educational content, not medical advice.